Answers are grounded in this paper and cite their sources.
Alzheimer’s disease (AD) is predicted to become the sixth leading cause of early death globally by 2040. Since the currently available treatment options are considered rather symptomatic, disease-modifying agents, mirroring a more in-depth understanding of the pathogenic mechanisms, are needed. There are some well-established pathogenic theories, but none of these are necessary, nor sufficient for pathogenesis. The inflammation pathogenic theory of the Alzheimer’s disease has been more and more studied for the last three decades, to try to fill the gap in the state of the art. One key player involved in the immune response of this chronic neuroinflammation is the human leukocyte antigen (HLA), the human equivalent of the major histocompatibility class. This paper reviews the current evidence for the involvement of the HLA system in the pathogenesis of Alzheimer’s disease.
No takes yet. Share an insight, caveat, or question.
Costescu et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: